Profound Medical (PROF) Current Assets (2018 - 2026)
Profound Medical's (PROF) quarterly Current Assets came in at $69.5 million in Q1 2026, up 16.05% year-on-year from $59.9 million in Q1 2025, and down 8.62% quarter-over-quarter from $76.1 million in Q4 2025.
Profound Medical (PROF) Current Assets (2018 - 2026) Analysis & Trends
Profound Medical's Current Assets history runs 9 years deep, the most recent figure standing at $69.5 million for Q1 2026.
- On a quarterly basis, Current Assets rose 16.05% year-over-year to $69.5 million in Q1 2026; TTM through Mar 2026 was $69.5 million, a 16.05% increase from a year earlier, with the FY2025 full-year figure at $76.1 million, up 10.17% from the prior year.
- Current Assets slipped to $69.5 million in Q1 2026 per PROF's latest filing, from $76.1 million in the prior quarter.
- Across five years, Current Assets topped out at $76.1 million in Q4 2025 and bottomed at $41.5 million in Q3 2025.
- The 5-year median for Current Assets is $61.0 million (2022), against an average of $58.6 million.
- Across the five-year window, Current Assets plunged 32.45% in 2023 and jumped 64.85% in 2024, its largest moves.
- Year by year, Current Assets stood at $62.0 million in 2022, then plunged by 32.45% to $41.9 million in 2023, then soared by 64.85% to $69.1 million in 2024, then increased by 10.17% to $76.1 million in 2025, then decreased by 8.62% to $69.5 million in 2026.
- Per Business Quant, the three latest PROF Current Assets figures stand at $69.5 million (Q1 2026), $76.1 million (Q4 2025), and $41.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | 69.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.53 Mn |
| Dec 31, 2025 | 76.09 Mn |
| Sep 30, 2025 | 41.52 Mn |
| Jun 30, 2025 | 48.81 Mn |
| Mar 31, 2025 | 59.91 Mn |
| Dec 31, 2024 | 69.07 Mn |
| Dec 31, 2023 | 41.90 Mn |
| Dec 31, 2022 | 62.02 Mn |
| Dec 31, 2021 | 77.13 Mn |
| Dec 31, 2020 | 97.74 Mn |
| Dec 31, 2019 | 22.44 Mn |
| Jan 1, 2019 | 27.80 Mn |
| Dec 31, 2018 | 28.73 Mn |